171 related articles for article (PubMed ID: 11845035)
21. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
22. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement.
Coticchia JM; Dohar JE
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):868-73. PubMed ID: 16230588
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
Miyazakin S; Yamaguchi K
Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
[No Abstract] [Full Text] [Related]
24. In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
Dhople AM; Ibanez MA
Antimicrob Agents Chemother; 1995 Sep; 39(9):2116-9. PubMed ID: 8540726
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
26. Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy.
Dohar J
Int J Pediatr Otorhinolaryngol; 2003 Dec; 67(12):1317-23. PubMed ID: 14643475
[TBL] [Abstract][Full Text] [Related]
27. Effect of ototopical medications on tympanostomy tube biofilms.
Oxley KS; Thomas JG; Ramadan HH
Laryngoscope; 2007 Oct; 117(10):1819-24. PubMed ID: 17690613
[TBL] [Abstract][Full Text] [Related]
28. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
29. Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.
Goldblatt EL; Dohar J; Nozza RJ; Nielsen RW; Goldberg T; Sidman JD; Seidlin M
Int J Pediatr Otorhinolaryngol; 1998 Nov; 46(1-2):91-101. PubMed ID: 10190709
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
31. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study.
Al Khorasani A; Banajeh S
J Infect; 2006 Oct; 53(4):228-34. PubMed ID: 16434101
[TBL] [Abstract][Full Text] [Related]
32. Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro.
Osburne MS; Murphy CK; Rothstein DM
J Antibiot (Tokyo); 2006 May; 59(5):303-8. PubMed ID: 16883781
[TBL] [Abstract][Full Text] [Related]
33. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.
Roland PS; Anon JB; Moe RD; Conroy PJ; Wall GM; Dupre SJ; Krueger KA; Potts S; Hogg G; Stroman DW
Laryngoscope; 2003 Dec; 113(12):2116-22. PubMed ID: 14660913
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
Brown SD; Rybak MJ
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
[TBL] [Abstract][Full Text] [Related]
35. Fungal causes of otitis externa and tympanostomy tube otorrhea.
Martin TJ; Kerschner JE; Flanary VA
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1503-8. PubMed ID: 15927274
[TBL] [Abstract][Full Text] [Related]
36. Acute otorrhea in children with tympanostomy tubes: prevalence of bacteria and viruses in the post-pneumococcal conjugate vaccine era.
van Dongen TM; Venekamp RP; Wensing AM; Bogaert D; Sanders EA; Schilder AG
Pediatr Infect Dis J; 2015 Apr; 34(4):355-60. PubMed ID: 25764097
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas biofilm formation after Haemophilus infection.
Ojano-Dirain C; Antonelli PJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):470-5. PubMed ID: 21493260
[TBL] [Abstract][Full Text] [Related]
38. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
Asbell PA; Colby KA; Deng S; McDonnell P; Meisler DM; Raizman MB; Sheppard JD; Sahm DF
Am J Ophthalmol; 2008 Jun; 145(6):951-958. PubMed ID: 18374299
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic ciprofloxacin drops after tympanostomy tube insertion.
Nawasreh O; Al-Wedyan IA
Saudi Med J; 2004 Jan; 25(1):38-40. PubMed ID: 14758376
[TBL] [Abstract][Full Text] [Related]
40. [Otorrhea on transtympanic aerator].
Essaadi M; François M; Mariani P
Arch Pediatr; 1997 Apr; 4(4):325-30. PubMed ID: 9183403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
